Skip to main content
Journal ArticleOPEN ACCESS

Chemotherapy with trifluridine/tipiracil prolongs progression-free survival time and improves quality of life A case report of 59-year-old woman with metastatic rectal cancer

  • Kania-Zembaczyńska B
OncoReview (2020) 10(1) 18-22
DOI: 10.24292/01.or.120310320
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

The paper presents a clinical case of a patient with a long-term response to IV line chemotherapy with trifluridine/tipiracil. The treatment allowed to maintain a good quality of life with acceptable side effects.

Cite

CITATION STYLE

APA

Kania-Zembaczyńska, B. (2020). Chemotherapy with trifluridine/tipiracil prolongs progression-free survival time and improves quality of life A case report of 59-year-old woman with metastatic rectal cancer. OncoReview, 10(1), 18–22. https://doi.org/10.24292/01.or.120310320

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free